form6k.htm
FORM
6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
For the
month of December,
2009
Commission
File Number: 00-30082
Envoy
Capital Group Inc.
(Translation
of registrant's name into English)
30 St.Patrick St., Ste. 301,
Toronto, Ontario, Canada M5T 3A3
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under
cover Form 20-F or Form 40-F.
Form 20-F
T Form
40-F £
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1): £
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7): £
Indicate
by check mark whether by furnishing the information contained in this Form, the
registrant is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes £ No T
If "Yes"
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82- __________
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
Envoy
Capital Group Inc.
|
|
|
(Registrant)
|
|
|
|
|
|
By:/s/ Andrew Patient
|
|
|
Name:
Andrew Patient
|
|
|
Title:
President and Chief
Executive
Officer
|
Dated:
December 23, 2009
Exhibit
Index
|
Exhibit
|
Description
|
|
|
|
|
|
|
|
Material
Change Report
|
|